Holen Sie sich die Stockscreener-App
0.6725
1.04%
0.0069
Handel nachbörslich:
.65
-0.0225
-3.35%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SCYX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.6656
Offen:
$0.654
24-Stunden-Volumen:
278.01K
Relative Volume:
0.55
Marktkapitalisierung:
$28.22M
Einnahmen:
$3.26M
Nettoeinkommen (Verlust:
$-19.52M
KGV:
-1.6813
EPS:
-0.4
Netto-Cashflow:
$-24.10M
1W Leistung:
+5.32%
1M Leistung:
+4.26%
6M Leistung:
-3.24%
1J Leistung:
-45.33%
1-Tages-Spanne:
$0.651
$0.677
1-Wochen-Bereich:
$0.6251
$0.677
52-Wochen-Spanne:
$0.565
$1.31
Scynexis Inc Stock (SCYX) Company Profile
Firmenname
Scynexis Inc
Sektor
Telefon
201-884-5485
Adresse
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Vergleichen Sie SCYX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCYX
Scynexis Inc
|
0.6725 | 27.93M | 3.26M | -19.52M | -24.10M | -0.40 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-22 | Eingeleitet | Guggenheim | Buy |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-11 | Hochstufung | Needham | Hold → Buy |
| 2018-06-27 | Eingeleitet | Maxim Group | Buy |
| 2017-10-24 | Eingeleitet | Guggenheim | Buy |
| 2017-07-10 | Eingeleitet | ROTH Capital | Buy |
| 2017-05-09 | Herabstufung | Needham | Buy → Hold |
| 2017-03-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-07 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2016-08-17 | Eingeleitet | Guggenheim | Buy |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-08-09 | Hochstufung | WBB Securities | Speculative Buy → Buy |
| 2016-03-28 | Eingeleitet | Brean Capital | Buy |
| 2015-12-29 | Eingeleitet | WBB Securities | Speculative Buy |
| 2015-11-16 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-06-10 | Eingeleitet | Needham | Buy |
| 2014-05-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2014-05-29 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Scynexis Inc Aktie (SCYX) Neueste Nachrichten
SCYNEXIS halts phase 3 MARIO trial, raising new questions for ibrexafungerp’s growth path - MSN
Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsJobs Report & Low Risk Investment Opportunities - ulpravda.ru
Why hedge funds are buying SCYNEXIS Inc. stockWeekly Trade Summary & AI Driven Price Predictions - ulpravda.ru
Gains Report: Does SCYNEXIS Inc stock trade at a discount to peersWeekly Trade Recap & Expert Curated Trade Ideas - moha.gov.vn
How SCYNEXIS Inc. stock compares to industry benchmarksOptions Play & Daily Stock Momentum Reports - ulpravda.ru
Why SCYNEXIS Inc. stock is trending among retail tradersResistance Breakout Alerts & Free Rapid Return Acceleration - bollywoodhelpline.com
Portfolio Update: How SCYNEXIS Inc stock compares to industry benchmarksJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - moha.gov.vn
SCYNEXIS granted Nasdaq extension to regain bid price compliance - MSN
What analysts say about SCYNEXIS Inc 135A stockFundamental Strength Indicators & Build Wealth With Expert Timing Advice - earlytimes.in
Scynexis receives 180-day extension from Nasdaq to meet listing requirements - Investing.com
Scynexis granted 180-day extension by Nasdaq to regain compliance with minimum bid price requirement - marketscreener.com
SCYNEXIS, Inc. Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Quiver Quantitative
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - The Manila Times
Earnings Report: Why SCYNEXIS Inc. stock is trending among retail tradersAnalyst Downgrade & Long Hold Capital Preservation Plans - Улправда
SCYNEXIS Earnings Notes - Trefis
Is SCYNEXIS Inc. stock trading at a premium valuationEarnings Risk Summary & Reliable Volume Spike Alerts - Улправда
Shorts Report: How SCYNEXIS Inc. (135A) stock compares with tech leadersEarnings Summary Report & Safe Entry Momentum Stock Tips - moha.gov.vn
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path - TipRanks
Will SCYNEXIS Inc. stock deliver better than expected guidance2025 Key Lessons & Advanced Swing Trade Entry Plans - DonanımHaber
Can SCYNEXIS Inc. stock continue upward trendEarnings Summary Report & Long-Term Growth Stock Strategies - Улправда
How SCYNEXIS Inc. (135A) stock compares with tech leadersJuly 2025 Momentum & Verified Stock Trade Ideas - Bölüm Sonu Canavarı
Why SCYNEXIS Inc. stock is a must watch in 2025Market Trend Review & Fast Momentum Stock Entry Tips - Улправда
Nasdaq Moves: Why SCYNEXIS Inc. stock is a must watch in 2025Weekly Stock Recap & AI Powered Market Trend Analysis - Улправда
Is SCYNEXIS Inc. stock a contrarian buy2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru
What insider purchases suggest about SCYNEXIS Inc. (135A) stockJuly 2025 Macro Moves & AI Enhanced Trading Alerts - ulpravda.ru
Revenue per share of SCYNEXIS, Inc. – BER:135A - TradingView — Track All Markets
SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World
Can SCYNEXIS Stock Hold Up When Markets Turn? - Trefis
Can SCYNEXIS Inc. stock surprise with earnings upsideVolume Spike & Real-Time Price Movement Reports - Newser
Why SCYNEXIS Inc. (135A) stock stays resilientWeekly Stock Report & Smart Swing Trading Techniques - Newser
How SCYNEXIS Inc. stock trades before earnings2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser
SCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
What is the fair value of SCYNEXIS Inc. stock nowEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is SCYNEXIS Inc. (135A) stock considered safe havenDollar Strength & Low Risk Investment Opportunities - Newser
Free cash flow per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView
Working capital per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView
Macro Review: Why SCYNEXIS Inc. stock is trending among retail tradersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Is SCYNEXIS Inc a good long term investmentGrowth Stock Opportunities & Exceptional Return Growth - Early Times
It is Poised to be a Bull Market for Scynexis Inc (SCYX) - Setenews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Investors in cash trouble should check out Scynexis Inc (SCYX) - Setenews
Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration - MSN
Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com
Finanzdaten der Scynexis Inc-Aktie (SCYX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):